Last reviewed · How we verify

NCT03571412

Antidepressive Effect on 5 Herz (Hz) rTMS Over Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal Cortex

Completed NA Last updated 16 April 2019
What this trial tests

NA trial testing repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder in 26 participants. Completed in 1 September 2017.

Timeline
8 August 2016
Primary endpoint
31 July 2017
1 September 2017

Quick facts

Lead sponsorUniversidad Autonoma de Queretaro
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment26
Start date8 August 2016
Primary completion31 July 2017
Estimated completion1 September 2017

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Autonoma de Queretaro

Who can join

Adults 18 to 45, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) over Left Dorsolateral Prefrontal Cortex and Dorsomedial Prefrontal Cortex on Major Depressive Disorder (MDD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of repetitive Transcranial Magnetic Stimulation

Trials testing the same drug.

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

Other Universidad Autonoma de Queretaro trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03571412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing